While a link between inflammatory signalling and BCL2 and BCL-xL has been proposed in the past32, further functional in-vitro and in-vivo validation experiments are warranted to corroborate the role of inflammatory response signalling and response to BCL2 inhibition in CLL. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.